Free Account Opening + AMC Free Demat
Loading...

Gland Pharma IPO vs Likhitha Infrastructure IPO

Comparision between Gland Pharma IPO and Likhitha Infrastructure IPO.

IPO Details

Gland Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Likhitha Infrastructure IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the Likhitha Infrastructure IPO is up to ₹61.20 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of Likhitha Infrastructure IPO is ₹120.00 per share.

  Gland Pharma IPO Likhitha Infrastructure IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹1,490.00 per share ₹116.00 per share
Issue Price (Upper) ₹1,500.00 per share ₹120.00 per share
Issue Price (Final) ₹1,500.00 per share ₹120.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 10 shares 125 shares
Fresh Issue Size 83,33,333 shares 51,00,000 shares
Fresh Issue Size (Amount) up to ₹1,250.00 Cr up to ₹61.20 Cr
OFS Issue Size 3,48,63,635 shares
OFS Issue Size (Amount) up to ₹5,229.55 Cr
Issue Size Total 4,31,96,968 shares 51,00,000 shares
Issue Size Total (Amount) up to ₹6,479.55 Cr up to ₹61.20 Cr

IPO Timetable

Gland Pharma IPO opens on Nov 09, 2020, while Likhitha Infrastructure IPO opens on Sep 29, 2020. The closing date of Gland Pharma IPO and Likhitha Infrastructure IPO is Nov 11, 2020, and Oct 07, 2020, respectively.

  Gland Pharma IPO Likhitha Infrastructure IPO
Anchor Bid Date
Issue Open Nov 09, 2020 Sep 29, 2020
Issue Close Nov 11, 2020 Oct 07, 2020
Basis Of Allotment (Tentative) Nov 17, 2020 Oct 12, 2020
Initiation of Refunds (Tentative) Nov 18, 2020 Oct 13, 2020
Credit of Share (Tentative) Nov 19, 2020 Oct 14, 2020
Listing date (Tentative) Nov 20, 2020 Oct 15, 2020
Anchor Lockin End date 1 Dec 17, 2020 Nov 11, 2020
Anchor Lockin End date 2 Feb 15, 2021 Jan 10, 2021

Financials

Gland Pharma IPO P/E ratio is , as compared to Likhitha Infrastructure IPO P/E ratio of .

  Gland Pharma IPO Likhitha Infrastructure IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 46,912.65 40,860.39 35,235.49 29,294.68
Total Revenue 9,162.89 27,724.08 21,297.67 16,716.82
Profit After Tax 3,135.90 7,728.58 4,518.56 3,210.51
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in lakhs)
31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 10,085.61 8,457.38 6,722.91
Total Revenue 16,279.02 14,054.68 8,860.56
Profit After Tax 1,987.93 1,785.51 716.22
Promoter Shareholding (Pre-Issue) 74% 99.96%
Promoter Shareholding (Post-Issue) 58% 74.11%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Gland Pharma IPO retail investors (RII) are offered 1,51,18,939 shares while in Likhitha Infrastructure IPO retail investors are offered 1,51,18,939 shares. Qualified institutional buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 51,000 shares in Likhitha Infrastructure IPO.

  Gland Pharma IPO Likhitha Infrastructure IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,39,394 shares 51,000 shares
NII 64,79,546 shares 32,64,000 shares
RII 1,51,18,939 shares 17,85,000 shares
Employee 0 shares 0 shares
Others
Total 3,02,37,879 shares 51,00,000 shares

Bids Received (Subscription)

Gland Pharma IPO subscribed 2.06x in total, whereas Likhitha Infrastructure IPO subscribed 9.51x.

  Gland Pharma IPO Likhitha Infrastructure IPO
QIB (times) 6.40x 21.99x
NII (times) 0.51x 1.54x
Big NII (times)
Small NII (times)
RII (times) 0.24x 23.71x
Employee (times)
Other (times)
Total (times) 2.06x 9.51x

Comments

Add a public comment...